Lungs News and Research

RSS

MRSA risk doubled in critically ill patients with glucose in their airways

Critically ill patients with glucose in their airways seem to be at double the risk of picking up serious hospital acquired infections, including MRSA, suggests research in Thorax.

1 Sep 2005

Compound called GRN163L blocks lung cancer

Researchers at UT Southwestern Medical Center have found a compound that shows promise as a way to block the spread, or metastasis, of lung cancer.

1 Sep 2005

Extra-virgin olive oil tastes good and is also an anti-inflammatory

After a tasting experience at a molecular gastronomy meeting in Sicily, biologist Gary Beauchamp of Pennsylvania University decided to analyse freshly pressed extra-virgin olive oil and found a chemical that acted like ibuprofen in the oil.

31 Aug 2005

Early life exposure to second-hand smoke can produce life-long respiratory problems

A new study finds early life exposure to second-hand smoke can produce life-long respiratory problems. The study of 35,000 adult non-smokers in Singapore found that those who lived with a smoker during childhood had more respiratory problems, including chronic cough.

30 Aug 2005

Significant advance in understanding how enzyme can prevent certain bacteria from becoming virulent

A team of biomedical researchers from Brandeis University and the University of Texas at Austin has determined the first 3-dimensional structure of an enzyme that may be pivotal in preventing certain bacterial infections in plants, animals and humans, according to a study published in the Proceedings of the National Academy of Sciences.

30 Aug 2005

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Chemotherapy is standard treatment for patients with advanced non-small cell lung cancer, although benefits are modest and toxicity substantial. Massimo Di Maio and colleagues hypothesised that neutropenia, a haematological toxicity, could be a predictor of drug activity and treatment efficacy.

30 Aug 2005

Viagra fights heart and lung diseases

German researchers have reported on the impact of Viagra on pulmonary hypertension at the Frontiers of Vascular Medicine Conference at Monash University this week.

30 Aug 2005

Study reveals functional link between emotion processing centers in the brain and certain physiological processes relevant to disease

The mere mention of a stressful word like "wheeze" can activate two brain regions in asthmatics during an attack, and this brain activity may be associated with more severe asthma symptoms, according to a study by University of Wisconsin-Madison researchers and collaborators.

29 Aug 2005

Ways to avoid hazards of heart bypass under study

The heart-lung bypass machine that stills the heart while surgeons bypass an adult’s clogged arteries or repair a baby’s malformed heart can also trigger a potentially deadly inflammatory response.

28 Aug 2005

Making human lungs in the lab a future possibility

Scientists in the UK say they have made a significant step towards making human lungs for transplantation.

25 Aug 2005

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.

25 Aug 2005

Quitting heroin under anesthesia is dangerous and ineffective

According to a new study, having a general anesthesia is not an effective way for heroin users to avoid the painful, drawn-out process of breaking their habit and can be dangerous.

24 Aug 2005

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus Therapeutics has announced the continued success in the development of its small molecule anticancer program with the selection of a sub-class of lead molecules from the Company's small molecule program.

24 Aug 2005

Scientists convert human embryonic stem cells into lung cells

According to research to be published in the journal Tissue Engineering, the team from Imperial College London, took human embryonic stem cells and 'directed' them to convert into the type of cells needed for gas exchange in the lung, known as mature small airway epithelium.

24 Aug 2005

A preoperative testing strategy may help determine stage of lung cancer more accurately

A preoperative testing strategy combining two procedures may help improve the accuracy of determining the stage of lung cancer, according to an article in the August 24/31 issue of JAMA: The Journal of the American Medical Association.

23 Aug 2005

Researchers test experimental drug Neuprex on infants undergoing heart surgery

UT Southwestern Medical Center is the only institution in the nation approved by the Food and Drug Administration to test an experimental drug on infants undergoing heart surgery to see whether it can help them avoid potentially lethal infections and improve survival.

22 Aug 2005

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

New guidelines to battle heart failure

Early diagnosis and new treatments can help battle heart failure -- a growing national problem that causes 1 million hospital admissions each year, according to new guidelines released by the American College of Cardiology (ACC) and the American Heart Association (AHA).

22 Aug 2005

Cancer Research Technology licenses novel cancer diagnostic markers

Cancer Research Technology Limited announced today that they have entered into a worldwide license agreement with TriPath Imaging, Inc.

22 Aug 2005

Mutations in the targets of designer drugs critically influence their effectiveness

Two designer cancer drugs differed dramatically in a laboratory test comparing their ability to shut down a mutant, overactive growth signal in lung cancer cells, reports a team headed by scientists at the Dana-Farber Cancer Institute.

18 Aug 2005

Lungs News and Research

MRSA risk doubled in critically ill patients with glucose in their airways

Compound called GRN163L blocks lung cancer

Extra-virgin olive oil tastes good and is also an anti-inflammatory

Early life exposure to second-hand smoke can produce life-long respiratory problems

Significant advance in understanding how enzyme can prevent certain bacteria from becoming virulent

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Viagra fights heart and lung diseases

Study reveals functional link between emotion processing centers in the brain and certain physiological processes relevant to disease

Ways to avoid hazards of heart bypass under study

Making human lungs in the lab a future possibility

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

Quitting heroin under anesthesia is dangerous and ineffective

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Scientists convert human embryonic stem cells into lung cells

A preoperative testing strategy may help determine stage of lung cancer more accurately

Researchers test experimental drug Neuprex on infants undergoing heart surgery

A cell's energy level is critical to its survival

New guidelines to battle heart failure

Cancer Research Technology licenses novel cancer diagnostic markers

Mutations in the targets of designer drugs critically influence their effectiveness

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News